# New Generation University College

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/new-generation-university-college/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 57.7 |
| Citations | 1,587,898 |
| City | Addis Ababa |
| Country | ET |
| Description | New Generation University College is a research organisation in Addis Ababa, ET. OpenAlex records 23,646 works and 1,587,898 citations for it. 5,984 researchers list it as their most recent affiliation. |
| Homepage | http://www.nguc.edu.et/ |
| OpenAlex ID | https://openalex.org/I2802457231 |
| Researchers | 5,984 |
| ROR ID | https://ror.org/015aem925 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q17071332 |
| Works | 23,646 |

## University papers

Showing 12 of 30.

- [Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment](https://scholariq.org/papers/asian-working-group-for-sarcopenia-2019-consensus-update-on-sarcopenia-diagnosis/)
- [Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial](https://scholariq.org/papers/pembrolizumab-versus-docetaxel-for-previously-treated-pd-l1-positive-advanced/)
- [Alectinib versus Crizotinib in Untreated <i>ALK</i>-Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/alectinib-versus-crizotinib-in-untreated-i-alk-i-positive-non-small-cell-lung/)
- [Virus-Enabled Synthesis and Assembly of Nanowires for Lithium Ion Battery Electrodes](https://scholariq.org/papers/virus-enabled-synthesis-and-assembly-of-nanowires-for-lithium-ion-battery/)
- [Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study](https://scholariq.org/papers/activity-and-safety-of-crizotinib-in-patients-with-alk-positive-non-small-cell/)
- [First-Line Lorlatinib or Crizotinib in Advanced <i>ALK</i> -Positive Lung Cancer](https://scholariq.org/papers/first-line-lorlatinib-or-crizotinib-in-advanced-i-alk-i-positive-lung-cancer/)
- [Capmatinib in <i>MET</i> Exon 14–Mutated or <i>MET</i> -Amplified Non–Small-Cell Lung Cancer](https://scholariq.org/papers/capmatinib-in-i-met-i-exon-14-mutated-or-i-met-i-amplified-non-small-cell-lung/)
- [Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study](https://scholariq.org/papers/epacadostat-plus-pembrolizumab-versus-placebo-plus-pembrolizumab-in-patients/)
- [Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial](https://scholariq.org/papers/dabrafenib-plus-trametinib-in-patients-with-previously-treated-brafv600e-mutant/)
- [Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma](https://scholariq.org/papers/polatuzumab-vedotin-in-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/)
- [Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib](https://scholariq.org/papers/predictive-and-prognostic-impact-of-epidermal-growth-factor-receptor-mutation-in/)
- [Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity](https://scholariq.org/papers/preclinical-comparison-of-osimertinib-with-other-egfr-tkis-in-egfr-mutant-nsclc/)

## University researchers

- [Dong‐Wan Kim](https://scholariq.org/researchers/dong-wan-kim/)
- [Tae Min Kim](https://scholariq.org/researchers/tae-min-kim/)

## University top topics

Showing 8 of 25.

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.